Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 10 - 26 source : Www.biospace.com save search
ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021
Published: 2021-10-26 (Crawled : 22:00) - biospace.com/
CLPT | $5.505 -0.09% -0.09% 55K
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
results
Masimo Reports Third Quarter 2021 Financial Results
Published: 2021-10-26 (Crawled : 22:00) - biospace.com/
MASI | $136.855 1.89% 1.85% 320K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
financial results results
Nurix Therapeutics to Present Initial Target Degradation Data from First Phase 1 Trial of NX-2127 in B Cell Malignancies at the 4th Annual Targeted Protein Degradation Summit
Published: 2021-10-26 (Crawled : 22:00) - biospace.com/
NRIX 6 d | $14.125 4.01% 3.86% 690K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
phase 1 trial t-cell
MacroGenics Announces Date of Third Quarter 2021 Financial Results Conference Call
Published: 2021-10-26 (Crawled : 22:00) - biospace.com/
MGNX | $16.23 5.32% 5.05% 650K
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
financial results results conference
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
Published: 2021-10-26 (Crawled : 22:00) - biospace.com/
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
kidney
Inari Medical to Announce Third Quarter 2021 Financial Results
Published: 2021-10-26 (Crawled : 22:00) - biospace.com/
NARI S | $37.13 -2.11% -2.15% 1.5M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
financial results results
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
BVS 4 | $4.29 0.0% 99K
|
|
| O: -0.6%
H: 0.0%
C: 0.0%
acquisition
Moderna Announces First Participant Dosed in Phase 3 Pivotal Registration Study of Its mRNA Cytomegalovirus (CMV) Vaccine
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
vaccine phase 3
Xilio Therapeutics Announces Closing of Initial Public Offering
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.33%
H: 0.0%
C: 0.0%
offering therapeutics publication
Electromed, Inc. Schedules its First Quarter Fiscal 2022 Financial Results Conference Call for November 9, 2021 at 5:00 p.m. ET
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
ELMD | $16.39 4.26% 0.0% 66K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
financial results results conference
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
disease neurodegenerative collaboration oda drug license
eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-10-26 (Crawled : 19:00) - biospace.com/
EFTR | $1.92 7.87% 7.29% 150K
|
|
| O: -1.89%
H: 0.0%
C: 0.0%
conference therapeutics
180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal Molecules
Published: 2021-10-26 (Crawled : 18:00) - biospace.com/
ATNF | $2.06 14.44% 12.62% 48K
|
|
| O: -0.19%
H: 0.0%
C: 0.0%
obesity pre-clinical life science preclinical
Secarna Pharmaceuticals and Denali Therapeutics Expand Strategic Partnership for the Discovery and Development of Novel ASO Therapeutics in the Field of CNS Diseases
Published: 2021-10-26 (Crawled : 18:00) - biospace.com/
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
disease partnership
Ensysce Biosciences Grows its Management Team with Appointment of Dr. Linda Pestano as Chief Development Officer
Published: 2021-10-26 (Crawled : 18:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K
|
Health Technology
|
| O: -2.75%
H: 0.0%
C: 0.0%
pest bioscience
Akari Therapeutics Announces Presentation at Annual Complement-Based Drug Development Summit
Published: 2021-10-26 (Crawled : 17:00) - biospace.com/
AKTX | $1.22 3.39% 3.28% 4.8K
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
presentation drug
Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer
Published: 2021-10-26 (Crawled : 17:00) - biospace.com/
VYNT | $0.194 -8.51% 19K
|
Health Care and Social Assistan...
|
| O: 0.47%
H: 0.0%
C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
Biocom California Announces Sixth Annual Life Science Catalyst Award Winners
Published: 2021-10-26 (Crawled : 17:00) - biospace.com/
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: 0.08%
H: 0.0%
C: 0.0%
life science awards
Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics DevelopmentGSK adds antibody discovery workflow to current cell line development process
Published: 2021-10-26 (Crawled : 17:00) - biospace.com/
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
antibody
Humanetics Corporation Adds Two New Experts to its Board
Published: 2021-10-26 (Crawled : 17:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.